Frankel Stanley

SEC Form 4 insider trading activity

Frankel Stanley has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Sep 30, 2026.

On the most recent filing, Frankel Stanley is listed as Director at PRECISION BIOSCIENCES INC. Inside the rolling window, Frankel Stanley reported 2 open-market purchases totaling $19K in DTIL and no open-market sales. The largest disclosed transaction in the window is a purchase of 2,700 DTIL shares on Dec 16, 2025, worth $13K.

Companies traded

Other insiders at DTIL

Insider Buying

$19K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
DTILPurchase$6KSep 30SEC ↗
DTILPurchase$13KDec 17SEC ↗
Showing 1–2 of 2
1 / 1

Earlier trades

Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.

DateTickerTypeValue
Sep 26, 2025DTILPurchase$13K
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Frankel Stanley made?

Frankel Stanley has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.

Which companies does Frankel Stanley trade?

Frankel Stanley has filed SEC Form 4 disclosures for 1 company, including DTIL.

When was Frankel Stanley's most recent SEC Form 4 filing?

Frankel Stanley's most recent SEC Form 4 filing on Tracefour is dated Sep 30, 2026.

What is Frankel Stanley's total buy and sell value in the current window?

Inside the rolling retention window, Frankel Stanley bought $19K and sold $0 based on SEC Form 4 filings.

What was Frankel Stanley's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 2,700 DTIL shares on 2025-12-16, worth $13K, per SEC Form 4 filings.